Grant: Idea to Innovation
University of Prince Edward Island
$123,500.00
Novel multiplex diagnostic assay for detection of economically-important salmonid pathogens using fluidic bead-based technology
EF 2013-14
Résumé
The objective of the proposed research is to improve the innovative molecular multiplex diagnostic assay that we conceptualized and initiated during the last two years into a form or product that can be utilized for detection of pathogens that affect salmon. The innovative product will detect simultaneously the 6 globally detrimental and economically damaging pathogens of salmon in a single sample in around 5 hours which are IHNV, ISAV, IPNV, SAV, VHSV and R. salmoninarum (the causative agent of BKD). Laboratory and field validation will be performed using the guidelines of World Organisation of Animal Health (OIE). The multiplex assay is expected to have higher or similar sensitivity and specificity, faster turnaround time and will be less costly on a per-test basis than the existing molecular diagnostic assay such as traditional PCR and real time PCR. This proposal will improve, characterize and document the performance of the novel assay so it can be marketed and utilized by potential users (salmon producers, regulatory agencies, veterinarians, aquatic specialists, epidemiologists, researchers, vaccine companies, etc.). After validation, the multiplex assay will be offered in a non-kit format at AVC-UPEI and can be licensed to private and government laboratories in Canada. It will be developed into a kit by an industry partner for marketing regionally, nationally and globally.The assay will aid in the diagnosis during viral outbreaks and can be incorporated into surveillance programs.
Programme
Idea to Innovation
Bénéficiaire
Emplacement
Prince Edward Island, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
453593-2013
Name nom
Yason, Carmencita
Department département
Pathology and Microbiology
Organization id
88
Institution établissement
University of Prince Edward Island
Province en
Prince Edward Island
Province fr
?le-du-Prince-Édouard
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2013
Competition year année de concours
2013
Award amount
123500
Program id
I2IPJ
Program name en
Idea to Innovation
Program name fr
De l'idée à l'innovation
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
106
Area of application group en
Agriculture and primary food production
Area of application group fr
Agriculture et produits alimentaires primaires
Area of application en
Aquaculture
Area of application fr
Aquiculture
Research subject code
5200
Research subject group en
Microbiology
Research subject group fr
Microbiologie
Research subject en
Microbiology
Research subject fr
Microbiologie
Partie
1
Nb partie
1
Application title
Novel multiplex diagnostic assay for detection of economically-important salmonid pathogens using fluidic bead-based technology
Keyword
NSERC
Application summary
The objective of the proposed research is to improve the innovative molecular multiplex diagnostic assay that we conceptualized and initiated during the last two years into a form or product that can be utilized for detection of pathogens that affect salmon. The innovative product will detect simultaneously the 6 globally detrimental and economically damaging pathogens of salmon in a single sample in around 5 hours which are IHNV, ISAV, IPNV, SAV, VHSV and R. salmoninarum (the causative agent of BKD). Laboratory and field validation will be performed using the guidelines of World Organisation of Animal Health (OIE). The multiplex assay is expected to have higher or similar sensitivity and specificity, faster turnaround time and will be less costly on a per-test basis than the existing molecular diagnostic assay such as traditional PCR and real time PCR. This proposal will improve, characterize and document the performance of the novel assay so it can be marketed and utilized by potential users (salmon producers, regulatory agencies, veterinarians, aquatic specialists, epidemiologists, researchers, vaccine companies, etc.). After validation, the multiplex assay will be offered in a non-kit format at AVC-UPEI and can be licensed to private and government laboratories in Canada. It will be developed into a kit by an industry partner for marketing regionally, nationally and globally.The assay will aid in the diagnosis during viral outbreaks and can be incorporated into surveillance programs.